Heron Therapeutics (HRTX) Cash from Investing Activities (QoQ) (2010 - 2026)
Heron Therapeutics (HRTX) Cash from Investing Activities (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Heron Therapeutics |
77.43 Mn |
47.47 Mn |
24.07 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
82.79% |
| Dec 31, 2025 |
-146.01% |
| Sep 30, 2025 |
61.69% |
| Jun 30, 2025 |
222.66% |
| Mar 31, 2025 |
-80.09% |
| Dec 31, 2024 |
187.61% |
| Sep 30, 2024 |
93.85% |
| Jun 30, 2024 |
60.25% |
| Mar 31, 2024 |
114.46% |
| Dec 31, 2023 |
61.95% |
| Sep 30, 2023 |
-275.68% |
| Jun 30, 2023 |
-64.11% |
| Mar 31, 2023 |
1,722.56% |
| Dec 31, 2022 |
105.61% |
| Sep 30, 2022 |
-282.46% |
| Jun 30, 2022 |
80.49% |
| Mar 31, 2022 |
145.12% |
| Dec 31, 2021 |
-212.13% |
| Sep 30, 2021 |
-45.50% |
| Jun 30, 2021 |
1,013.84% |
